Advancing Cancer Treatment by Targeting Glutamine Metabolism-A Roadmap

Area of Science:

• Oncology
• Metabolic pathways
• Cancer cell biology

Background:

• Tumor growth and metastasis are critically dependent on cancer cell metabolic adaptation.
• Cancer cells alter their metabolism to meet energy demands and overcome the tumor microenvironment.
• Glutamine metabolism is a key pathway that can be targeted for cancer treatment.

Purpose of the Study:

• To review metabolic and molecular pathways linked to dysregulated glutamine metabolism in various cancer types.
• To summarize current clinical trials investigating glutaminolysis inhibition.
• To explore combined treatment strategies targeting glutamine metabolism alongside other pathways for potential clinical application.

Main Methods:

• Literature review of metabolic and molecular pathways in cancer.
• Analysis of clinical trial data for glutaminolysis inhibitors.
• Discussion of combined therapeutic strategies.

Main Results:

• Glutamine dependence in many tumors is linked to mitochondrial glutaminase (GLS) activity, impacting TCA cycle, ATP/NADPH generation, and redox balance.
• GLS inhibitors limit cancer energy supply and increase oxidative stress, but some cancers evade this by metabolic reprogramming.
• Sole reliance on glutamine inhibition has limited effectiveness due to cancer's metabolic adaptability.

Conclusions:

• Dysregulated glutamine metabolism is a hallmark of many cancers.
• While glutaminolysis inhibition shows therapeutic potential, resistance mechanisms necessitate alternative or combined strategies.
• Combined treatments targeting glutamine metabolism with other pathways hold promise for enhanced clinical efficacy in cancer therapy.